Bavamian et al. (2015)identified increased expression of human (hsa)-miR-34a in postmortem cerebellartissue from BD patients, as well as in BD patient-derived iPSC-neuronal cultures.Hsa-miR-34a targets multiple genes implicated as genetic risk factors for BD,including ankyrin-3 (ANK3) and voltage-dependent L-type calcium channel subunitbeta-3 (CACNB3). This evidence concerns the gene ANK3 and Behcet disease.